FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Andrew Mosholder

Research Profile

Concepts & Ideas

Organizations

United States Food and Drug Administration

Geographic Areas

United States

Chemicals & Drugs

Living Beings

Activities & Behaviors

Disorders

Co-author Network

Publications

TOP 3
Andrew D Mosholder; John J Alexander; Justin Mathew; Harry Smith; Sumathi Nambiar
Cardiovascular risks with azithromycin and other antibacterial drugs.
Tamra E Meyer; David Moeny; Andrew D Mosholder; Rita P Ouellet-Hellstrom; Lockwood G Taylor; James R Williams; Suji Xie; David J Graham; Trinka S Coster
Neuropsychiatric events in varenicline and nicotine replacement patch users in the Military Health System.
Ann W McMahon; Andrew D Mosholder; Mark S Levenson; Bradley W McEvoy; Dianne Murphy
Age and risks of FDA-approved long-acting β₂-adrenergic receptor agonists.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Andrew Mosholder (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Andrew D Mosholder; John J Alexander; Justin Mathew; Harry Smith; Sumathi Nambiar
Cardiovascular risks with azithromycin and other antibacterial drugs.
The New England journal of medicine 2013;368(18):1665-8.
2013: Tamra E Meyer; David Moeny; Andrew D Mosholder; Rita P Ouellet-Hellstrom; Lockwood G Taylor; James R Williams; Suji Xie; David J Graham; Trinka S Coster
Neuropsychiatric events in varenicline and nicotine replacement patch users in the Military Health System.
Addiction (Abingdon, England) 2013;108(1):203-10.
2011: Ann W McMahon; Andrew D Mosholder; Mark S Levenson; Bradley W McEvoy; Dianne Murphy
Age and risks of FDA-approved long-acting β₂-adrenergic receptor agonists.
Pediatrics 2011;128(5):e1147-54.
2010: Carol A Pamer; TA Hammad; Yu-Te Wu; Sigal Kaplan; George Rochester; Laura Governale; Andrew D Mosholder
Changes in US antidepressant and antipsychotic prescription patterns during a period of FDA actions.
Pharmacoepidemiology and drug safety 2010;19(2):158-74.
2010: TA Hammad; Andrew D Mosholder
Suicide and antidepressants. Beware extrapolation from ecological data.
BMJ (Clinical research ed.) 2010;341():c6844.
2009: Paula Gish; Andrew D Mosholder; Melissa Truffa; Rosemary Johann-Liang
Spectrum of central anticholinergic adverse effects associated with oxybutynin: comparison of pediatric and adult cases.
The Journal of pediatrics 2009;155(3):432-4.
2009: Andrew D Mosholder; Kate Gelperin; TA Hammad; Kathleen Phelan; Rosemary Johann-Liang
Hallucinations and other psychotic symptoms associated with the use of attention-deficit/hyperactivity disorder drugs in children.
Pediatrics 2009;123(2):611-6.
2006: Andrew D Mosholder; Carol A Pamer
Postmarketing surveillance of suicidal adverse events with pediatric use of antidepressants.
Journal of child and adolescent psychopharmacology 2006;16(1-2):33-6.
2006: Andrew D Mosholder; Mary Willy
Suicidal adverse events in pediatric randomized, controlled clinical trials of antidepressant drugs are associated with active drug treatment: a meta-analysis.
Journal of child and adolescent psychopharmacology 2006;16(1-2):25-32.
2003: Kathleen M Phelan; Andrew D Mosholder; Susan Lu
Lithium interaction with the cyclooxygenase 2 inhibitors rofecoxib and celecoxib and other nonsteroidal anti-inflammatory drugs.
The Journal of clinical psychiatry 2003;64(11):1328-34.